L3VLUP
ProSign in

COGT · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

COGTLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • COGT
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterCOGTLLY
Q3 2020none listed holders, n.a.33 holders, $14.1bn
Q4 20202 holders, $8.0m29 holders, $17.3bn
Q1 20212 holders, $6.4m24 holders, $23.0bn
Q2 20212 holders, $17m24 holders, $27.8bn
Q3 20211 holders, $5.0m31 holders, $29.9bn
Q4 20211 holders, $5.1m31 holders, $34.7bn
Q1 20221 holders, $6.4m24 holders, $35.3bn
Q2 20221 holders, $9.0m33 holders, $42.7bn
Q3 20221 holders, $3.7m31 holders, $43.4bn
Q4 20223 holders, $11m31 holders, $46.6bn
Q1 20234 holders, $63m33 holders, $44.3bn
Q2 20233 holders, $93m37 holders, $59.6bn
Q3 20234 holders, $59m44 holders, $67.6bn
Q4 20233 holders, $35m45 holders, $73.6bn
Q1 20243 holders, $53m41 holders, $95.3bn
Q2 20244 holders, $97m43 holders, $110bn
Q3 20244 holders, $120m45 holders, $107bn
Q4 20244 holders, $47m46 holders, $93.9bn
Q1 20253 holders, $42m42 holders, $98.4bn
Q2 20253 holders, $43m43 holders, $93.2bn
Q3 20254 holders, $92m39 holders, $86.7bn
Q4 20259 holders, $1.3bn41 holders, $123bn
Q1 202611 holders, $1.6bn39 holders, $106bn
Q2 20267 holders, $1.6bn44 holders, $132bn
COGT

Cogent Biosciences Inc

Holders
4
Reported value
$92m
Buyers
2
Sellers
1

Breadth +1 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
LLY

Eli Lilly & Co

Holders
39
Reported value
$86.7bn
Buyers
22
Sellers
22

Breadth 0 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2025

Among the 40 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only COGT (1)

Farallon Capital Management LLC

Only LLY (36)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Man Group PLC, Marshall Wace LLP, Millennium Management LLC, and 11 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →